Advances in Radiotherapy and Prognosis
Topic Information
Dear Colleagues,
Radiotherapy plays an important role in cancer treatment and has progressed toward personalization. In addition to improving accuracy using advanced technology, it is also very important to identify patients with a high risk of recurrence. These patients need more aggressive treatments, such as chemotherapy, target therapy, and immunotherapy. This relies on the use of clinical information and blood laboratory data. Additionally, pathological information from immunohistochemistry (IHC) and genetic alteration is useful for the evaluation of prognosis. The high and low levels of these biomarkers can be used to classify patients at risk of recurrence for the basis of future clinical trials to changes in radiation dose escalation/de-escalation or treatment volume. This Topic will focus on the clinical treatment effects of the above concepts. In addition, various precise treatments, such as particle therapy and stereotactic body radiotherapy (SBRT) and comparison of the effects of different radiation doses/volumes, are welcome in terms of treatment technology. Original and review articles are welcome to enrich the literature and the scientific community.
Prof. Dr. Eng-Yen Huang
Prof. Dr. Yi-Wei Chen
Topic Editors
Keywords
- radiotherapy
- tumor marker
- biomarker
- prognostic factor
- particles therapy
- proton therapy
- stereotactic body radiotherapy
- treatment outcome
Participating Journals
18,259 Articles
Launched in 2013
4.5Impact Factor
7.8CiteScore
18 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
37,981 Articles
Launched in 2009
4.8Impact Factor
9.0CiteScore
18 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
5,840 Articles
Launched in 1994
3.6Impact Factor
6.1CiteScore
23 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
54,359 Articles
Launched in 2012
3.3Impact Factor
5.2CiteScore
17 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q1Highest JCR Category Ranking
184 Articles
Launched in 2021
-Impact Factor
3.3CiteScore
21 DaysSubmission to First Decision
5 DaysAcceptance to Publication
-Highest JCR Category Ranking
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
i. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
ii. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
iii. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
iv. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
v. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.